EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Anemia, iron metabolism, and anemia medication habits in patients undergoing maintenance hemodialysis and peritoneal dialysis are different: a multicenter investigation

Yumei Liu, Ruifeng Yang, Wenyi Teng, Leyi Gu, Chunli Yu, Zhenfang Du, Ying Li, Xiujuan Zang, Jun Chao, Hui Yu, Niansong Wang

Clinical and Experimental Nephrology · 2025

DOI: 10.1007/s10157-024-02594-4 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical and Experimental Nephrology, 2025. Verfasst von Yumei Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Yishan Road, Shanghai, Chi…. Hauptthemen laut MEDLINE: Renal Dialysis, Peritoneal Dialysis, Iron, Hematinics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Hospital-Level Subject Project of the Shanghai Sixth People's Hospital, Hospital-Level Subject Project of the Shanghai Sixth People’s Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: This study aimed to investigate anemia, iron metabolism status, and treatment in patients undergoing maintenance hemodialysis (HD) and peritoneal dialysis (PD). METHODS: Patients aged ≥ 18 years undergoing HD and PD were surveyed using a case report form to collect information. RESULTS: Data were collected from 1071 patients undergoing HD and 630 undergoing PD at eight centers. Anemia was observed in 96.2% of the patients (96.7% for HD vs. 95.2% for PD, P = 0.121). Of these, 38.3% had hemoglobin (Hb) levels between 110 and 130 g/L (41.2% for HD vs. 33.3% for PD, P < 0.001), 22.8% had absolute iron deficiency (ID) (31.2% for HD vs. 8.4% for PD, P < 0.001), and 5.8% had functional ID (4.7% for HD vs. 7.6% for PD, P = 0.012). Among patients with Hb < 110 g/L, 13.0% received no treatment with erythropoiesis-stimulating agents (ESAs, all recombinant human erythropoietin) or hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI, all roxadustat) (12.6% for HD vs. 13.6% for PD, P = 0.667), while 64.6% had no iron treatment (69.4% for HD vs. 57.4% for PD, P < 0.001). Logistic regression was used to explore the relationship between dialysis mode and hemoglobin target achievement, suggesting that the attainment of hemoglobin targets may be associated with the use of ESAs or HIF-PHI. CONCLUSION: Anemia, iron metabolism, and medication habits have distinct characteristics in patients undergoing HD and PD. Iron deficiency is prevalent, and achieving hemoglobin targets is suboptimal, possibly influenced by the administration of ESAs or HIF-PHI. Therefore, timely adjustments of medication habits are necessary to prevent anemia exacerbation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisPeritoneal DialysisIronHematinicsAnemiaAnemia, Iron-DeficiencyHumansMaleFemaleMiddle AgedAgedHemoglobinsAdultBiomarkers

Stichwörter der Autor:innen

AnemiaHemodialysisHemoglobinIron deficiencyPeritoneal dialysis

Substanzen

HemoglobinsIronHematinicsBiomarkers

Autor:innen und Institutionen

  • Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Yishan Road, Shanghai, China.
  • Nursing Department, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Nephrology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Integrated Traditional Chinese and Western Medicine Nephropathy and Rheumatology Department, Jinshan Branch of Shanghai Sixth People's Hospital, Shanghai, China.
  • Department of Nephrology, Zhangjiagang TCM Hospital, Affiliated to Nanjing University of Chinese Medicine, Jiangsu Province, China.
  • Department of Nephrology, Jiading Central Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China.

Förderung

  • Hospital-Level Subject Project of the Shanghai Sixth People's Hospital
  • Hospital-Level Subject Project of the Shanghai Sixth People’s Hospital

Zitieren

APA

Liu, Y., Yang, R., Teng, W., Gu, L., Yu, C., Du, Z., Li, Y., Zang, X., Chao, J., Yu, H., & Wang, N. (2025). Anemia, iron metabolism, and anemia medication habits in patients undergoing maintenance hemodialysis and peritoneal dialysis are different: a multicenter investigation. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-024-02594-4

Vancouver

Liu Y, Yang R, Teng W, Gu L, Yu C, Du Z, et al. Anemia, iron metabolism, and anemia medication habits in patients undergoing maintenance hemodialysis and peritoneal dialysis are different: a multicenter investigation. Clinical and Experimental Nephrology. 2025. doi:10.1007/s10157-024-02594-4

BibTeX
@article{Liu2025,
  author = {Liu, Yumei and Yang, Ruifeng and Teng, Wenyi and Gu, Leyi and Yu, Chunli and Du, Zhenfang and Li, Ying and Zang, Xiujuan and Chao, Jun and Yu, Hui and Wang, Niansong},
  title = {Anemia, iron metabolism, and anemia medication habits in patients undergoing maintenance hemodialysis and peritoneal dialysis are different: a multicenter investigation},
  journal = {Clinical and Experimental Nephrology},
  year = {2025},
  doi = {10.1007/s10157-024-02594-4}
}
Kostenlos starten →